Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Muus

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Leukemia|March 13, 2001
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearanceM Smeets, R Raymakers, P Muus, et al.
Annals of Hematology|May 1, 1994
In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicityN Van der Lely, T De Witte, J Wessels, et al.
Experimental Cell Research|September 1, 1988
Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cellsC Van den Bogert, P Muus, C Haanen, et al.
International Journal of Hematology|June 8, 2011
Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemiaM L H Cuijpers, D J van Spronsen, P Muus, et al.
The British Journal of Dermatology|April 8, 2014
Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumabE F M Otters, G Zarafonitis, E J Steenbergen, et al.
British Journal of Haematology|June 1, 1997
All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemiaA Kentos, F Le Moine, L Crenier, et al.
Bone Marrow Transplantation|November 1, 1994
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remissionT De Witte, B Awwad, J Boezeman, et al.
Leukemia|April 1, 1997
Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cellsM J Kroef, M J Bolk, P Muus, et al.
Thrombosis Research|July 7, 2015
Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumabS T A van Bijnen, B Østerud, W Barteling, et al.
Behring Institute Mitteilungen|August 1, 1988
GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cellsT De Witte, P Muus, C Haanen, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Leukemia|March 13, 2001
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearanceM Smeets, R Raymakers, P Muus, et al.
Annals of Hematology|May 1, 1994
In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicityN Van der Lely, T De Witte, J Wessels, et al.
Experimental Cell Research|September 1, 1988
Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cellsC Van den Bogert, P Muus, C Haanen, et al.
International Journal of Hematology|June 8, 2011
Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemiaM L H Cuijpers, D J van Spronsen, P Muus, et al.
The British Journal of Dermatology|April 8, 2014
Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumabE F M Otters, G Zarafonitis, E J Steenbergen, et al.
British Journal of Haematology|June 1, 1997
All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemiaA Kentos, F Le Moine, L Crenier, et al.
Bone Marrow Transplantation|November 1, 1994
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remissionT De Witte, B Awwad, J Boezeman, et al.
Leukemia|April 1, 1997
Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cellsM J Kroef, M J Bolk, P Muus, et al.
Thrombosis Research|July 7, 2015
Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumabS T A van Bijnen, B Østerud, W Barteling, et al.
Behring Institute Mitteilungen|August 1, 1988
GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cellsT De Witte, P Muus, C Haanen, et al.
Pageof 7